Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-18

FDA Approved: CLINDAMYCIN PHOAPHATE TOPICAL SOLUTION USP, 1% — Supplemental Application (Encube Ethicals, Inc.)

View source ↗

Summary

FDA approves a supplemental application for CLINDAMYCIN PHOAPHATE TOPICAL SOLUTION USP, 1% (ANDA 209914) by Encube Ethicals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLINDAMYCIN PHOAPHATE TOPICAL SOLUTION USP, 1% (CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP, 1%)

Snippet

SUPPL AP for CLINDAMYCIN PHOAPHATE TOPICAL SOLUTION USP, 1% (CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP, 1%)